Form 8-K - Current report:
SEC Accession No. 0001193125-26-232631
Filing Date
2026-05-20
Accepted
2026-05-20 16:18:43
Documents
11
Period of Report
2026-05-19
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d103157d8k.htm   iXBRL 8-K 41460
  Complete submission text file 0001193125-26-232631.txt   153059

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA bdsx-20260519.xsd EX-101.SCH 3169
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE bdsx-20260519_lab.xml EX-101.LAB 17234
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bdsx-20260519_pre.xml EX-101.PRE 10805
15 EXTRACTED XBRL INSTANCE DOCUMENT d103157d8k_htm.xml XML 3531
Mailing Address 919 WEST DILLON ROAD LOUISVILLE CO 80027
Business Address 919 WEST DILLON ROAD LOUISVILLE CO 80027 303-417-0500
BIODESIX INC (Filer) CIK: 0001439725 (see all company filings)

EIN.: 203986492 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39659 | Film No.: 261004288
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)